The global population of intestinal tumors is very large, with 1.93 million new cases of colon and rectal cancer and 916,000 deaths in 2020, according to statistics from the World Health Organization (WHO). Intestinal tumors have a significant impact on the health and quality of life of people worldwide.

There is a peak season for gastrointestinal diseases from June to October each year, with symptoms such as diarrhea, abdominal pain, belching, and loss of appetite, which become a hidden burden for those with gastrointestinal discomfort.

Dragana Rogulja, a neuroscientist at Harvard Medical School, published a research paper titled: Sleep Loss Can Cause Death through Accumulation of Reactive Oxygen Species in the Gut in the top international academic journal Cell, proposing that the cause of sudden death induced by staying up late is not in the brain and heart,

IBD and IBS are two common gastrointestinal disorders that affect millions of people worldwide. They have similarities, but also differences between them.

Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease that mainly involves the digestive system, and Crohn's disease (CD) and ulcerative colitis (UC) are the main types of it. Common complications of UC include toxic megacolon, colonic stenosis, intestinal obstruction, intestinal bleeding, intestinal perforation, colon polyps, and colon cancer; common complications of CD include fistula, abdominal abscess, intestinal obstruction, and perianal lesions, less likely to develop into a cancer.